First Trust Direct Indexing L.P. Raises Stock Position in Fresenius Medical Care AG (NYSE:FMS)

First Trust Direct Indexing L.P. boosted its position in shares of Fresenius Medical Care AG (NYSE:FMS) by 9.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,901 shares of the company’s stock after purchasing an additional 2,021 shares during the period. First Trust Direct Indexing L.P.’s holdings in Fresenius Medical Care were worth $488,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. Wulff Hansen & CO. raised its stake in Fresenius Medical Care by 1,809.0% during the second quarter. Wulff Hansen & CO. now owns 343,429 shares of the company’s stock worth $6,556,000 after purchasing an additional 325,439 shares during the period. Triasima Portfolio Management inc. raised its stake in Fresenius Medical Care by 27.4% during the second quarter. Triasima Portfolio Management inc. now owns 85,430 shares of the company’s stock worth $1,631,000 after purchasing an additional 18,360 shares during the period. QRG Capital Management Inc. raised its stake in Fresenius Medical Care by 10.9% during the second quarter. QRG Capital Management Inc. now owns 60,309 shares of the company’s stock worth $1,151,000 after purchasing an additional 5,946 shares during the period. Creative Planning raised its stake in Fresenius Medical Care by 18.9% during the second quarter. Creative Planning now owns 40,140 shares of the company’s stock worth $766,000 after purchasing an additional 6,373 shares during the period. Finally, Ritholtz Wealth Management raised its stake in Fresenius Medical Care by 2.5% during the second quarter. Ritholtz Wealth Management now owns 36,901 shares of the company’s stock worth $704,000 after purchasing an additional 895 shares during the period. 8.25% of the stock is owned by hedge funds and other institutional investors.

Fresenius Medical Care Price Performance

Fresenius Medical Care stock opened at $19.76 on Monday. The company’s 50 day simple moving average is $20.33 and its 200-day simple moving average is $20.20. The company has a market capitalization of $11.60 billion, a price-to-earnings ratio of 20.37, a price-to-earnings-growth ratio of 0.95 and a beta of 0.91. Fresenius Medical Care AG has a 1 year low of $16.66 and a 1 year high of $22.76. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.09 and a current ratio of 1.46.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. StockNews.com assumed coverage on shares of Fresenius Medical Care in a research note on Friday. They issued a “strong-buy” rating on the stock. Truist Financial boosted their price target on shares of Fresenius Medical Care from $22.00 to $23.00 and gave the company a “hold” rating in a research note on Monday, October 7th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $23.00.

Fresenius Medical Care Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.